Evidence reviewed: 8 November 2026. Bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC, often called a vaginal yeast infection) can both cause vaginal discomfort or discharge, but they have different causes and require different medicines. BV involves disruption of the usual vaginal bacterial community, whereas yeast infection results from symptomatic growth of Candida species. BV may cause a noticeable odor and thin discharge; yeast infection more often causes itching, soreness and inflammation. Symptoms overlap, however, so appearance alone is not a reliable diagnosis. The CDC and WHO recommend targeted clinical assessment and treatment rather than repeated self-prescribing [1–3].
What is bacterial vaginosis?
The vagina normally contains a community of bacteria, often dominated by Lactobacillus species that help maintain a relatively acidic environment. BV involves a shift away from this pattern toward greater diversity of anaerobic organisms, including Gardnerella and other BV-associated bacteria. BV is associated with a characteristic thin homogeneous white or gray discharge and sometimes a fishy odor, especially after sex, although many people are asymptomatic [1].
BV is not a simple infection caused by one bacterium, and it is not evidence of poor hygiene. Sexual activity, new partners, lack of condom use and vaginal douching are associated with BV, but it can occur without sexual activity and is not classified in exactly the same way as a typical single-pathogen STI [1].
What is a vaginal yeast infection?
Vulvovaginal candidiasis causes symptomatic inflammation due to Candida species, most often Candida albicans. Candida can also be present without symptoms, and a positive test alone does not always require treatment. People may develop VVC during pregnancy, after antibiotic exposure, with poorly controlled diabetes or with immune compromise, but it often occurs without any obvious risk factor [2].
Typical symptoms include intense vulvar itching, burning, irritation, discomfort during intercourse or urination, and thick white discharge in some cases. Not everyone develops the classic “cottage cheese” discharge, and yeast infections do not always involve discharge at all. The condition should not be assumed from itching alone, because dermatitis, vulvar skin disorders and other infections may resemble it.
BV versus yeast infection: comparison
| Feature | Bacterial vaginosis | Vaginal yeast infection |
|---|---|---|
| Cause | Vaginal bacterial community disruption involving multiple anaerobic organisms | Symptomatic Candida overgrowth and inflammatory response |
| Discharge | Often thin, uniform white or gray | May be thick, white and clumpy, or minimal |
| Odor | Fishy odor may be present | Usually not strongly fishy |
| Itching and irritation | May occur but often not dominant | Frequently prominent |
| Vaginal pH | Often greater than 4.5 | Usually normal acidic pH below 4.5 |
| Typical treatment | Metronidazole or clindamycin under appropriate guidance | Azole antifungals such as clotrimazole or miconazole; selected oral fluconazole use |
| Pregnancy | Treat symptomatic BV with pregnancy-appropriate regimens | Use topical azoles for seven days, not routine oral fluconazole |
These are patterns, not diagnostic rules. Trichomoniasis and other STIs, contact dermatitis, retained foreign bodies or mixed infections may cause similar discharge, odor or inflammation. Both BV and yeast infection can coexist, so a clinician may need to test for more than one condition [1,2].
Which symptoms require urgent evaluation?
Seek prompt assessment for pelvic or lower abdominal pain, fever, significant bleeding, sores, a new rash or severe symptoms. These may indicate a different problem such as pelvic inflammatory disease or a genital infection that requires another treatment. Pregnancy with pelvic pain, bleeding or systemic illness requires urgent clinical evaluation.
Also arrange assessment when symptoms recur, persist despite an appropriate treatment, occur for the first time or arise after a new STI exposure. A self-diagnosed yeast infection may actually be BV, trichomoniasis or a vulvar condition that antifungals will not help.
How is bacterial vaginosis diagnosed?
Clinicians may use Amsel clinical criteria, Nugent Gram-stain scoring or selected validated nucleic acid amplification tests (NAATs) in symptomatic patients. The four Amsel findings are:
- Thin, homogeneous discharge coating vaginal walls.
- Vaginal pH greater than 4.5.
- Clue cells observed under microscopy.
- A characteristic fishy amine odor, sometimes enhanced after addition of potassium hydroxide.
Meeting three of four Amsel criteria supports BV [1]. Nugent scoring assesses the balance of bacterial morphotypes on a Gram-stained vaginal smear. Molecular panels can detect BV-associated bacterial patterns but should be used according to validation, symptoms and local availability; a positive molecular test in an asymptomatic person is not automatically an indication for treatment.
How is a yeast infection diagnosed?
VVC diagnosis is supported by a compatible clinical presentation and identification of yeast, budding forms or pseudohyphae on saline or KOH microscopy, or by appropriate culture or other validated testing [2]. A normal vaginal pH supports candidiasis over BV but is not a stand-alone diagnostic test.
If microscopy is negative despite convincing symptoms, a clinician may consider fungal culture. Cultures are particularly useful for recurrent, severe or treatment-resistant symptoms because Candida glabrata and other non-albicans organisms may not respond to usual short courses and may be difficult to identify on routine microscopy [2].
Recommended treatment for symptomatic BV
The CDC STI Treatment Guidelines list three standard first-line options for appropriate nonpregnant patients with symptomatic BV [1]:
| Regimen | Typical CDC recommendation |
|---|---|
| Oral metronidazole | 500 mg twice daily for 7 days. |
| Metronidazole 0.75% vaginal gel | 5 g once daily for 5 days. |
| Clindamycin 2% vaginal cream | 5 g at bedtime for 7 days. |
These are published reference regimens, not a personalized prescription. A clinician must consider pregnancy, allergies, tolerability, other medicines and local guidance. WHO guidance also supports oral metronidazole 400–500 mg twice daily for seven days and alternatives where available [3].
Clindamycin vaginal cream can weaken latex condoms and diaphragms for several days after use. Douching is not recommended and may increase recurrence. The CDC no longer finds convincing evidence for the frequently repeated claim that a disulfiram-like reaction requires everyone to abstain from alcohol during metronidazole treatment; individual medicine labels, adverse effects and advice still matter [1].
Recommended treatment for uncomplicated VVC
The CDC lists topical azoles, including clotrimazole or miconazole, often for one to seven days according to product, as well as fluconazole 150 mg orally once for eligible nonpregnant patients with uncomplicated VVC [2]. Drug choice depends on pregnancy status, severity, interacting medicines and previous response.
Antibiotics such as metronidazole do not treat Candida. Conversely, fluconazole and antifungal creams do not reliably treat BV. Using both treatments without establishing a diagnosis can cause unnecessary side effects and miss an STI or noninfectious skin disorder.
Pregnancy precautions
Symptomatic BV during pregnancy should be assessed and treated, because it has been associated with adverse pregnancy outcomes. The CDC considers standard metronidazole regimens appropriate in selected pregnant patients and reports a low risk of teratogenicity with metronidazole based on available data; treatment decisions remain clinician-directed [1].
For yeast infection during pregnancy, the CDC recommends topical azole therapy for seven days only. Do not use routine oral fluconazole during pregnancy, because observational studies raise concern about miscarriage and congenital abnormalities [2]. New vaginal discharge during pregnancy can have other causes and should be evaluated appropriately.
Do probiotics, yogurt or vaginal washes cure these infections?
There is insufficient evidence to substitute probiotics for recommended BV or VVC treatments. The CDC does not support commercially available probiotics as routine replacement or adjunctive BV therapy, and does not find substantial evidence for probiotic treatment of VVC [1,2]. Applying yogurt, antiseptics or household products inside the vagina can cause irritation and obscure diagnosis.
The vagina usually requires no internal cleansing. Gentle external hygiene is sufficient. Avoid douching and fragranced vaginal products that irritate the vulva or disrupt local bacterial balance.
What if symptoms return after treatment?
Recurrence is common, particularly for BV. It may reflect persistence or re-emergence of the original bacterial pattern, other exposures, reinfection with particular organisms or an incorrect initial diagnosis. Persistent yeast symptoms may arise from non-albicans species, antifungal resistance or a noninfectious skin disorder [1,2].
Do not repeatedly purchase the same medicine without reevaluation. A clinician may recommend repeat testing, species identification, STI screening and a recurrence-specific treatment plan. New evidence about treating partners of selected people with recurrent BV is covered in our companion recurrent BV and recurrent yeast infection guide.
Frequently asked questions
Does a fishy smell always mean bacterial vaginosis?
No. It is suggestive but not definitive. Examination and appropriate testing can distinguish BV from STIs or other causes.
Does a white discharge always mean yeast infection?
No. Discharge appearance alone cannot establish the diagnosis.
Can I take fluconazole for BV?
No. Fluconazole treats certain fungal infections, not BV-associated bacterial imbalance.
Is BV the same as an STI?
BV is a polymicrobial vaginal condition associated with sexual activity and STI risk, but is not equivalent to infection by one classic STI pathogen [1].
Is oral fluconazole suitable during pregnancy?
No, not as routine treatment for VVC. CDC recommends topical azoles for seven days [2].
Should an asymptomatic positive Candida culture always be treated?
No. Colonization without symptoms may be normal and does not automatically warrant treatment [2].
Key takeaways
BV and vaginal yeast infections have different mechanisms and treatments. Odor, pH and discharge may provide clues, but testing is important when diagnosis is uncertain. Metronidazole or clindamycin treats symptomatic BV; suitable azole antifungals treat VVC. Pregnancy, recurrent symptoms and possible STIs change the management plan.
References
- Centers for Disease Control and Prevention. Bacterial vaginosis: STI treatment guidelines. CDC; accessed 8 Nov 2026.
- Centers for Disease Control and Prevention. Vulvovaginal candidiasis: STI treatment guidelines. CDC; accessed 8 Nov 2026.
- World Health Organization. Recommendations for treatment of bacterial vaginosis and vulvovaginal candidiasis. WHO; 2024.
Medical disclaimer: Educational information, not an individualized diagnosis or prescription. New or persistent vaginal symptoms, pelvic pain, fever, pregnancy-associated symptoms or STI exposure require clinical assessment. Drug regimens are examples from guidelines and must be prescribed or selected appropriately.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.